The role for optical density in heparin-induced thrombocytopenia: A cohort study

Chest

Volumn 148, Issue 1, 2015, Pages 55-61

  Chan, Chee M ^a   Woods, Christian J ^a   Warkentin, Theodore E ^b   Sheppard, Jo Ann I ^b   Shorr, Andrew F ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ADULT; ARTICLE; ASSAY; DIAGNOSTIC ACCURACY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPTICAL DENSITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEROTONIN RELEASE; SEROTONIN RELEASE ASSAY; THROMBOSIS PREVENTION; AGED; CHEMICALLY INDUCED; COHORT ANALYSIS; COMPLICATION; HOSPITALIZATION; MIDDLE AGED; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; ANTICOAGULANTS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; ROC CURVE; SENSITIVITY AND SPECIFICITY; THROMBOCYTOPENIA;

EID: 84937539728     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1417     Document Type: Article

References (17)

1. Warkentin TE. Agents for the treatment of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2010;24(4):755-775.
2. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood. 2005;106(8):2710-2715.
3. Warkentin TE, Greinacher A, Gruel Y, Aster RH, Chong BH; Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498-2500.
4. Lee GM, Arepally GM. Diagnosis and management of heparin-induced thrombocytopenia. Hematol Oncol Clin North Am. 2013;27(3):541-563.
5. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of eparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2-suppl):e495S-e530S.
6. Cuker A, Ortel TL. ASH evidence-based guidelines: is the IgG-specific anti-PF4/heparin ELISA superior to the polyspecific ELISA in the laboratory diagnosis of HIT? Hematology (Am Soc Hematol Educ Program). 2009;250-252.
7. Chong BH. Heparin-induced thrombocytopenia. J Thromb Haemost. 2003;1(7):1471-1478.
8. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759-765.
9. Pouplard C, Leroux D, Regina S, Rollin J, Gruel Y. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies. Thromb Haemost. 2010;103(1):145-150.
10. Bakchoul T, Giptner A, Bein G, Santoso S, Sachs UJ. Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT). Thromb Res. 2011;127(4):345-348.
11. Warkentin TE, Sheppard JI, Moore JC, Sigouin CS, Kelton JG. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost. 2008;6(8):1304-1312.
12. Zwicker JI, Uhl L, Huang WY, Shaz BH, Bauer KA. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004;2(12):2133-2137.
13. Baroletti S, Hurwitz S, Conti NA, Fanikos J, Piazza G, Goldhaber SZ. Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med. 2012;125(1):44-49.
14. Janatpour KA, Gosselin RC, Dager WE, et al. Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia. Am J Clin Pathol. 2007;127(3):429-433.
15. Whitlatch NL, Perry SL, Ortel TL. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparininduced thrombocytopenia. Thromb Haemost. 2008;100(4):678-684.
16. Demma LJ, Winkler AM, Levy JH. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Anesth Analg. 2011;113(4):697-702.
17. Chan CM, Corso PJ, Sun X, Hill PC, Shorr AF. Evaluating the role for the optical density in the diagnosis of heparininduced thrombocytopenia following cardiac surgery. Thromb Haemost. 2011;106(5):934-938.